Article in Nanomedicine (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Lorena Bonilla-VidalDepartment of Pharmacy, Pharmaceutical Technology & Physical Chemistry, University of Barcelona, Barcelona, 08028, Spain.ORCID 0000-0002-2043-2092
Marta ŚwitalskaDepartment of Experimental Oncology, Ludwik Hirszfeld Institute of Immunology & Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53-114, Wrocław, Poland.ORCID 0000-0001-7920-2251
Marta EspinaDepartment of Pharmacy, Pharmaceutical Technology & Physical Chemistry, University of Barcelona, Barcelona, 08028, Spain.ORCID 0000-0003-1269-3847
Joanna WietrzykDepartment of Experimental Oncology, Ludwik Hirszfeld Institute of Immunology & Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53-114, Wrocław, Poland.ORCID 0000-0003-4980-6606
Maria Luisa GarcíaDepartment of Pharmacy, Pharmaceutical Technology & Physical Chemistry, University of Barcelona, Barcelona, 08028, Spain.ORCID 0000-0002-4526-3344
Eliana B SoutoLaboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira, 228, Porto, 4050-313, Portugal.ORCID 0000-0002-9737-6017
Anna GliszczyńskaDepartment of Food Chemistry & Biocatalysis, Wrocław University of Environmental & Life Sciences, Norwida 25, 50-375, Wrocław, Poland.ORCID 0000-0002-0218-6369
Elena Sánchez-LópezDepartment of Pharmacy, Pharmaceutical Technology & Physical Chemistry, University of Barcelona, Barcelona, 08028, Spain.ORCID 0000-0003-2571-108X
Funding
Agència de Gestió d'Ajuts Universitaris i de Recerca LLAV 0004FCT-Fundação para a Ciência e a Tecnologia UIDB/04378/2020Spanish Ministry of Science and Innovation PID2021-122187NB-C32
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Antitumoral melatonin-loaded nanostructured lipid carriers. · full record | OpenQuestion